1. Home
  2. FFIN vs ALKS Comparison

FFIN vs ALKS Comparison

Compare FFIN & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Bankshares Inc.

FFIN

First Financial Bankshares Inc.

HOLD

Current Price

$30.96

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$28.49

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFIN
ALKS
Founded
1890
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.7B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
FFIN
ALKS
Price
$30.96
$28.49
Analyst Decision
Hold
Strong Buy
Analyst Count
2
13
Target Price
$37.50
$42.85
AVG Volume (30 Days)
914.0K
1.9M
Earning Date
01-22-2026
02-11-2026
Dividend Yield
2.44%
N/A
EPS Growth
16.54
2.44
EPS
1.69
2.02
Revenue
$581,881,000.00
$1,521,338,000.00
Revenue This Year
$21.45
N/A
Revenue Next Year
$6.75
$24.22
P/E Ratio
$18.44
$14.19
Revenue Growth
14.03
1.08
52 Week Low
$29.80
$25.17
52 Week High
$39.12
$36.45

Technical Indicators

Market Signals
Indicator
FFIN
ALKS
Relative Strength Index (RSI) 46.68 45.90
Support Level $30.61 $27.69
Resistance Level $31.49 $28.98
Average True Range (ATR) 0.55 0.80
MACD -0.01 0.03
Stochastic Oscillator 32.21 45.37

Price Performance

Historical Comparison
FFIN
ALKS

About FFIN First Financial Bankshares Inc.

First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto. It derives maximum revenue from Construction and Development Segment.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: